UK markets open in 2 hours 38 minutes
NIKKEI 225
32,787.77 +479.91 (+1.49%) HANG SENG
16,019.16 -315.21 (-1.93%) CRUDE OIL
71.65 +0.42 (+0.59%) GOLD FUTURES
2,013.10 -1.40 (-0.07%) DOW
36,247.87 +130.47 (+0.36%) Bitcoin GBP
33,616.88 -1,426.05 (-4.07%)
Chugai Pharmaceutical Co., Ltd. (CHGCY)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EST
| Previous close | 18.65 |
| Open | 17.98 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 17.98 - 19.06 |
| 52-week range | 11.93 - 19.06 |
| Volume | |
| Avg. volume | 69,004 |
| Market cap | 61.202B |
| Beta (5Y monthly) | 0.54 |
| PE ratio (TTM) | 26.21 |
| EPS (TTM) | 0.71 |
| Earnings date | N/A |
| Forward dividend & yield | 0.29 (1.55%) |
| Ex-dividend date | 29 Jun 2023 |
| 1y target est | N/A |
ZacksChugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY) Is a Great Choice for 'Trend' Investors, Here's Why
If you are looking for stocks that are well positioned to maintain their recent uptrend, Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
ZacksChugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY) Upgraded to Buy: Here's What You Should Know
Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
© 2023 Yahoo. All rights reserved.